Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68071-3638

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-3638). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3638 3)

This text appears to be a product label for Venlafaxine Hydrochloride 37.5mg capsules. It includes important information such as warnings, dosage details, manufacturer information, lot numbers, NDC codes, and expiration dates. The label also provides instructions to contact a doctor in case of side effects and how to report side effects to the FDA. The product should be stored at a controlled temperature of 68-77°F.*

FDA Label Image

Image-01 (Image 01)

FDA Label Image

Image-02 (Image 02)

This appears to be a list of factors related to special populations like those with hepatocirrhosis, hepatic impairment, moderate hepatic impairment, renal impairment, hemodialysis, CYP2D6 polymorphism, poor/extensive metabolizers, age over 80 years, and gender differences (females/males) in the context of analyzing the effects on a specific analyte called venlafaxine. It also includes data on fold change and confidence intervals in pharmacokinetics.*

FDA Label Image

Image-03 (Image 03)

This text shows a list of drugs and their interactions with venlafaxine in terms of PK Fold Change and 90% CI. The drugs mentioned include ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The text provides information on changes in maximum plasma concentration (Cmax) and area under the curve (AUC) relative to the reference value for each drug interaction.*

FDA Label Image

Image-04 (Image 04)

This text appears to list interacting drugs and analytes, including names like Ethanor, Diazepam, Alprazolam, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. It also mentions fold change and 90% CI in relation to reference values. This information could potentially be used for evaluating drug interactions or analyzing concentrations of substances in a sample.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.